• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory

    Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies

    Waters Corp. Acquires Light Scattering Company Wyatt Technology
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    Peptide Aggregation - A Complex Topic

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Traceability & 2D Barcodes

    Complex in Complex – New Hopes for Better Drug Delivery in Topical Dosage Formulation

    Proactive Resource Group Offers DSCSA Services for Pharma Companies

    Catalent Adds New Cryogenic Capabilities at Japanese Facility

    TraceLink, PharmaLink Partner to Simplify DSCSA Compliance
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?

    FDA Watch: Is Your Supply Chain at Risk?

    FDA Watch: CDER to Launch Guidance Snapshot Pilot Program
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Almac Group

    INCOG BioPharma Services

    Alcami

    Quotient Sciences
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Almac Group

    INCOG BioPharma Services

    Alcami

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Five Insights to Maximize Customer-Centric Acquisition Growth

    Keeping it all together for the sake of multi-dimensional value.

    Five Insights to Maximize Customer-Centric Acquisition Growth
    A celebration of the Actylis brand reveal takes place at the company’s China office, part of a global series of launch events. (Courtesy: Actylis)
    Five Insights to Maximize Customer-Centric Acquisition Growth
    Actylis’s newest facility in Eugene, Oregon in the U.S. represents the company’s investments. The 28,000-square-foot facility includes five suites for Phase 1 and Phase 2 cGMP manufacturing and reactors up to 400 liters.
    Edward Roullard, SVP Marketing and Operations, Actylis02.06.23
    Acquisitions can expand a company’s size, range, and reach, but the process to get there is not without its growing pains.

    Acquisitions and subsequent integrations are highly dynamic and situation-dependent processes, so unfortunately, it’s not difficult to lose or shift focus along the way. When this happens in a worst-case scenario, a company becomes larger, yet its acquired parts are discordant and out of step with customer needs and expectations.

    Actylis was constructed specifically through an ambitious and continuing acquisition initiative—integrating 11 organizations in just over two years—to close known gaps in the market. Our aim is to become a leading hybrid manufacturing and global sourcing expert for ingredients and raw materials. We’ve learned much along our acquisition journey.

    Here, we share five insights to successfully acquire and integrate brands in a complex field, and to do so while continuing to satisfy and delight customers.

    Customer is King: Focus on What’s Important

    Customers are the lifeblood of a company. Satisfying and even elating customers drives short- and long-term growth, deepens a sense of community and partnership, and helps others to reach new levels of innovation and discovery.

    With each acquisition and subsequent integration, we communicated and shared a principle that serving our customer is top priority. This served two purposes. First, it helped drive an integration of cultures. Second, it served as a guidepost for our teams to balance necessary integration activities with appropriately serving our customers.

    This principle also meant investing millions of dollars in our acquired companies. With updated and expanded capabilities, particularly with U.S.-based manufacturing, and a significantly larger overall company size, our customers can increase confidence and reduce risk.

    For example, one customer has already expanded their reliance on our products. We are working with them to supply five of their most critical raw materials, up from two prior to our acquisitions.

    Our customer care includes active communication to understand customer needs and anticipate their forward-looking forecasts. We’re also integrating and expanding our digital resources on the Actylis website so that customers can quickly find the exact information that they need.

    Acquisitions mean that companies aren’t the same as they were yesterday. By proactively centering around the customer’s needs and best interests, businesses can remain at the forefront of growth opportunities. This sustains a feedback loop of focused commitment to the customer.

    Planning Is Everything: Set Strategic Criteria

    Acquisitions can be a lucrative growth strategy so long as the targets fill an internal gap and meet an external need. Losing sight of these objectives amongst the complex, dynamic acquisition process can alienate customers and drive them to alternate sources.

    Uniquely serving the customer through a hybrid model of manufacturing and global sourcing is central to our mission. With that in mind, we have compiled a set of criteria for an ideal acquisition target to meet.

    Priority is given to European and U.S.-based targets producing raw materials for the life sciences segment, and to those with niche technical capabilities. Having these criteria ensures focus and drives efficiency.

    And while we haven’t yet found an acquisition to meet all stringent criteria, we also haven’t expected to find one. Instead, we’ve found several strong manufacturers that met most of the criteria and were also able to leverage off each other.

    For example, we acquired four North American manufacturing facilities. Under the larger umbrella of Actylis, these facilities can now leverage their respective expertise with each other to drive best practices in efficiency, quality, and service. This often-forgotten synergy adds tremendous value to the customer.

    Focused acquisitions bring expertise and opportunity. A broad portfolio can, in turn, streamline customer sourcing workflows so that they can focus on their own product processes and corporate goals.

    Obstacles are Opportunities: Be Flexible and Agile

    Unexpected hurdles are common during the acquisition process. How companies react to these hurdles can make the difference between failure, mediocrity, and success.

    The COVID-19 pandemic hit as we were closing our very first acquisition in the United Kingdom. It didn’t derail our plans, but it did compel us to think and act differently with this and subsequent acquisitions.

    We were forced to develop relationships remotely, and we closed some acquisitions without being able to travel to the facility. There was a fair bit of trepidation in this new and evolving process; and a whole lot of learning.

    The silver lining is that our acquisition process and roadmap are far more efficient today because of the pandemic.

    Another unexpected curveball was the internal reaction to our investment plan. In some cases, we came in with an aggressive plan to upgrade the acquired company to drive growth and further serve customers.

    These investment plans were positively received, but once the acquisition newness wore off, reality hit. Big investments mean big changes. Change can be daunting, especially for those on the receiving end.

    From this, we learned to be hyper-sensitive to the changes that we’re bringing along, and phase them in a way that could be effectively absorbed. This way, internal staff is prepared, roles and actions are clarified, and change can proceed with little to no customer-facing disruption.

    Happiness Starts from Within: Cultivate Internal Culture

    Curiosity drives us. It’s part of our corporate culture. Culture doesn’t hide behind the curtains though; it is woven into internal and external interactions. A strong positive culture shines through to customers and reinforces the value that we provide.

    During integration retrospectives, we asked each acquired company’s owners for feedback. One made a valuable recommendation to speak more to acquired employees about company culture, norms, and how decisions are made.

    We now hold a “culture orientation meeting” within a few weeks of each acquisition close. The teams interface with us as new owners and talk about fundamental topics such as why the company was bought, what will change, and forward-reaching expectations. Our ultimate objective is for transparency about where the culture was, where it is now, and where we want to go.

    Any acquisition integration brings with it change. We share with employees a standard change curve that most companies and employees go through. It is an acknowledgement of understanding, a great reminder to existing and new leaders that we need to be there for employees, and a point of reference for employees as they move along in the journey.

    With each acquisition, we prioritized integration of our productivity and communication platforms to facilitate internal dialogue. This may seem minor, but especially during the pandemic and with less travel, it was a must-have.

    Rebranding also helped tremendously to energize all the entities. The new company name, Actylis, united all 11 acquired companies (to date) in a fresh start instead of some being swept into a bigger established brand.

    There’s a palpable excitement in the new brand; everyone is a brand ambassador.

    This energy translates into going the extra mile for customers and following through on our brand promise of unparalleled choice, reliable supply, and uniquely flexible solutions.

    Haste Makes Waste: Pace Yourself

    Finding the optimal pace is just as important to companies as it is to individuals. An operational pace that’s too fast can lead to burnout or hasty actions and decisions whereas a pace that’s too slow can impede forward momentum. Neither situation serves customers well.

    We organize our integrations with various workstreams made up of individuals across entities.  With the first couple of integrations, these teams were very ambitious and comprehensive in their plans. We quickly realized that the teams were taking on too much; this was a lot for the acquired company to handle, and it was also a lot for us to handle as the primary company, especially as acquisitions stacked up on each other.

    It made sense for us to take a step back and assess the overarching situation. For each acquisition, we assess what is mission critical for success versus what will be nice to have. We are able to prioritize those top items, while pacing the rest.
    This approach has empowered teams to work together at a pace that doesn’t disrupt the business yet also keeps us moving forward.

    In addition to avoiding shortsighted actions and frustration, this also keeps our customers at the heart of our evolution.

    Summary

    It’s not possible to eliminate all risk or unknowns when acquiring and integrating companies, especially those that support highly regulated industries. On the other hand, it is possible to cultivate acquisitions into a singular source of purpose-built customer value. One that creates new opportunities for the acquired brands, capabilities for the parent company, and above all, lives up to the brand potential from the customer’s perspective. 


    Ed Roullard is SVP of Marketing & Operations at Actylis (formerly Aceto) with oversight for operations, supply chain, IT, and marketing. He comes to Actylis with over 25 years in the life sciences and fine chemicals industries. Roullard has held senior roles in marketing, sales, supply chain management, operations, process improvement, distributor management, and strategy in Europe and the U.S.
      Loading, Please Wait..
      Trending
      • Aurigene Expands Biologics CDMO Capacity
      • Astellas To Transfer Manufacturing Plant To Delpharm
      • Catalent Adds New Cryogenic Capabilities At Japanese Facility
      • Thermo Fisher Expands Steriles Facility In Asia-Pacific Region
      • Lifecore Biomedical Enters Into $150M New Financing Deal
      Breaking News
      • AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
      • Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
      • JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
      • Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
      • Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies
      View Breaking News >
      CURRENT ISSUE

      May 2023

      • New Modalities Hog the Limelight
      • Cell and Gene Therapy is Coming of Age
      • Demand Surges for Cell and Gene Therapy Contract Manufacturing
      • Embracing a New Reality
      • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
      • Single-Use Technologies Enable Biologic Scaling
      • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
      • FTEs in Drug Discovery
      • Digital Transformation in Pharma
      • What is a Manufacturing Ecosystem and Why are They Growing?
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
      BGG Receives Patent for Saw Palmetto ID Method
      Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
      Coatings World

      Latest Breaking News From Coatings World

      Boeing Starts Construction on New St. Louis Facility
      Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
      BCF Calls for Greater Urgency on REACH Impasse
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      CareDx, Miromatrix Collaborate on Bioengineered Organs Research
      Capitainer Releases to Market its Fully Automated Sample Handler
      Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
      JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
      Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Beautycounter Names New Interim CEO
      Shaz & Kiks Available at Sephora
      Stetson Introduces Men’s Grooming Portfolio
      Happi

      Latest Breaking News From Happi

      Shaz and Kiks Launches at Sephora
      Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
      Unilever Ventures’ Backs Selva Ventures in $34 Million Fund for Early-Stage CPG Brands
      Ink World

      Latest Breaking News From Ink World

      ACTEGA, Makro Labelling to Advance Signite Technology
      BCF Requests Greater Urgency on REACH Impasse
      Updated Method Published for Entire BASF Product Portfolio
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      ACTEGA teams with Makro Labelling to advance Signite technology
      Constantia Flexibles and SB Packagings commence joint venture
      Inland donates new VersaStudio printer to local high school
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Mann+Hummel Names President Air Filtration Americas
      KNH Launches Eco-Friendly Menstrual Pads
      Niine Introduces India's First PLA-Based Sanitary Pads
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Enrollment Completed in Anika Therapeutics' Hyalofast Study
      Exactech Releases Next-Gen GPS Shoulder
      Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      onsemi Presents Path to Accelerate Revenue Growth
      STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
      Graphene Flagship to Join Euro Nano Forum 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login